123 Main Street, New York, NY 10001

Top Navigation with Mega Menu
Investor Relations
Changing the Future

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

Learn More

Latest News
Stock Information
Thursday, May 9, 2024
4:30pm - 5:30pm EDT

Co-Dx Q1 2024 Earnings Webcast

Thursday, March 14, 2024
4:30pm - 5:30pm EDT

Co-Dx Q4/FY 2023 Earnings Webcast

All Events

Join Our Newsletter

Receive our latest blog posts directly in your inbox!